122 related articles for article (PubMed ID: 15061559)
1. Sharing of noninjection drug-use implements as a risk factor for hepatitis C.
Tortu S; McMahon JM; Pouget ER; Hamid R
Subst Use Misuse; 2004 Jan; 39(2):211-24. PubMed ID: 15061559
[TBL] [Abstract][Full Text] [Related]
2. A potential hidden source of hepatitis C infection among noninjecting drug users.
McMahon JM; Tortu S
J Psychoactive Drugs; 2003; 35(4):455-60. PubMed ID: 14986874
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City.
Diaz T; Des Jarlais DC; Vlahov D; Perlis TE; Edwards V; Friedman SR; Rockwell R; Hoover D; Williams IT; Monterroso ER
Am J Public Health; 2001 Jan; 91(1):23-30. PubMed ID: 11189819
[TBL] [Abstract][Full Text] [Related]
4. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City.
Howe CJ; Fuller CM; Ompad DC; Galea S; Koblin B; Thomas D; Vlahov D
Drug Alcohol Depend; 2005 Sep; 79(3):389-95. PubMed ID: 16102381
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack.
Macías J; Palacios RB; Claro E; Vargas J; Vergara S; Mira JA; Merchante N; Corzo JE; Pineda JA
Liver Int; 2008 Jul; 28(6):781-6. PubMed ID: 18312289
[TBL] [Abstract][Full Text] [Related]
6. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection among noninjecting drug users in New York City.
Koblin BA; Factor SH; Wu Y; Vlahov D
J Med Virol; 2003 Jul; 70(3):387-90. PubMed ID: 12767001
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.
Fuller CM; Ompad DC; Galea S; Wu Y; Koblin B; Vlahov D
J Urban Health; 2004 Mar; 81(1):20-4. PubMed ID: 15047780
[TBL] [Abstract][Full Text] [Related]
9. The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco.
Hermanstyne KA; Bangsberg DR; Hennessey K; Weinbaum C; Hahn JA
J Public Health (Oxf); 2012 Aug; 34(3):330-9. PubMed ID: 22451327
[TBL] [Abstract][Full Text] [Related]
10. Sharing of Snorting Straws and Hepatitis C Virus Infection in Pregnant Women.
Fernandez N; Towers CV; Wolfe L; Hennessy MD; Weitz B; Porter S
Obstet Gynecol; 2016 Aug; 128(2):234-237. PubMed ID: 27400008
[TBL] [Abstract][Full Text] [Related]
11. Noninjection drug use: an under-appreciated risk factor for hepatitis C virus transmission.
Martinez A; Talal AH
Liver Int; 2008 Jul; 28(6):757-60. PubMed ID: 18647138
[No Abstract] [Full Text] [Related]
12. Intranasal transmission of hepatitis C virus: virological and clinical evidence.
Aaron S; McMahon JM; Milano D; Torres L; Clatts M; Tortu S; Mildvan D; Simm M
Clin Infect Dis; 2008 Oct; 47(7):931-4. PubMed ID: 18764772
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
[TBL] [Abstract][Full Text] [Related]
14. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts.
Baozhang T; Kaining Z; Jinxing K; Ruchang X; Ming L; Caixia Z; Li T
Epidemiol Infect; 1997 Dec; 119(3):343-7. PubMed ID: 9440438
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.
McFall AM; Solomon SS; Lucas GM; Celentano DD; Srikrishnan AK; Kumar MS; Mehta SH
Addiction; 2017 Aug; 112(8):1480-1487. PubMed ID: 28317210
[TBL] [Abstract][Full Text] [Related]
18. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico.
Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K
Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029
[TBL] [Abstract][Full Text] [Related]
19. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C among noninjecting drug users: a report.
Tortu S; Neaigus A; McMahon J; Hagen D
Subst Use Misuse; 2001 Mar; 36(4):523-34. PubMed ID: 11346280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
